Emcure Pharmaceuticals Ltd
Company Profile
Business description
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics. The company operates in Derma, Women’s Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives. Geographically, it operates in India, Europe, Canada, Vietnam, Dubai, and Other Countries.
Contact
Plot No. P-1 and P-2, IT-BT Park
Phase II, M.I.D.C.
Hinjawadi
PuneMH411 057
INDT: +91 2035070033
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
11,474
Stocks News & Analysis
stocks
Anglo American strikes deal to create a new copper giant
stocks
The ‘other’ AI chip behemoth that might just be getting started
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,063.70 | 16.80 | -0.19% |
CAC 40 | 7,761.32 | 11.93 | 0.15% |
DAX 40 | 23,632.95 | 85.50 | -0.36% |
Dow JONES (US) | 45,490.92 | 220.42 | -0.48% |
FTSE 100 | 9,225.39 | 17.14 | -0.19% |
HKSE | 26,106.40 | 93.86 | -0.36% |
NASDAQ | 21,886.06 | 6.57 | 0.03% |
Nikkei 225 | 44,126.28 | 288.61 | 0.66% |
NZX 50 Index | 13,213.16 | 63.08 | -0.48% |
S&P 500 | 6,532.04 | 19.43 | 0.30% |
S&P/ASX 200 | 8,797.10 | 16.70 | -0.19% |
SSE Composite Index | 3,852.01 | 39.79 | 1.04% |